Recessive truncating IGHMBP2 mutations presenting as axonal sensorimotor neuropathy
Authors:
- Gudrun SchottmannGSGudrun Schottmann
- Heinz JungbluthHJHeinz Jungbluth
- Ulrike ScharaUSUlrike Schara
- Ellen KnierimEKEllen Knierim
- Susanne Morales GonzalezSGSusanne Morales Gonzalez
- Esther GillEGEsther Gill
- Franziska SeifertFSFranziska Seifert
- Fiona NorwoodFNFiona Norwood
- Charu DeshpandeCDCharu Deshpande
- Katja von AuKAKatja von Au
- Markus SchuelkeMSMarkus Schuelke
- Jan SenderekJSJan Senderek
- 3 February 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (5) , 523-531
Abstract
Objective: To identify the cause of sensorimotor neuropathy in a cohort of patients with genetically unsolved neuropathies (57 families with a total of 74 members) in whom hitherto known disease genes had been excluded. Methods: We used autozygosity mapping or haplotype analysis to delineate potential disease loci in informative families. For mutation detection, we used either whole-exome sequencing or Sanger sequencing of positional candidates. Subsequently, a larger cohort was specifically screened for IGHMBP2 mutations. The pathogenicity of a splice-site mutation was verified in cultured patient skin fibroblasts on the messenger RNA level and by Western blot. Results: We report on 5 patients with neuropathy from 3 families who carried truncating mutations in IGHMBP2. Contrary to the “classic” phenotype, they did not manifest with respiratory distress, but with progressive sensorimotor neuropathy. Only one patient required nocturnal mask ventilation, while 4 others maintained normal respiratory function by the age of 14, 18, 22, and 37 years. Three patients were still able to walk independently. All patients had a predominantly axonal sensorimotor neuropathy with subsequent muscle atrophy, but without obvious sensory symptoms. Two patients had signs of autonomic neuropathy. Conclusions: Mutations in IGHMBP2 should be considered in the molecular genetic workup of patients with hereditary sensorimotor neuropathies, even in the absence of respiratory symptoms.Keywords
This publication has 24 references indexed in Scilit:
- The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1Nucleic Acids Research, 2012
- HomozygosityMapper2012--bridging the gap between homozygosity mapping and deep sequencingNucleic Acids Research, 2012
- Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old manNeuromuscular Disorders, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to PTRF-CAVIN MutationsPLOS Genetics, 2010
- IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)Human Molecular Genetics, 2009
- Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survivalHuman Molecular Genetics, 2005
- Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1Human Genetics, 2004
- Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)Human Molecular Genetics, 2004